Small GTPase R-Ras Regulates Integrity and Functionality of Tumor Blood Vessels
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Summary We show that R-Ras, a small GTPase of the Ras family, is essential for the establishment of mature, functional blood vessels in tumors. The genetic disruption of R-Ras severely impaired the maturation processes of tumor vessels in mice. Conversely, the gain of function of R-Ras improved vessel structure and blood perfusion and blocked plasma leakage by enhanced endothelial barrier function and pericyte association with nascent blood vessels. Thus, R-Ras promotes normalization of the tumor vasculature. These findings identify R-Ras as a critical regulator of vessel integrity and function during tumor vascularization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 5×
“The plasma leakage from tumor vessels elevates the interstitial fluid pressure within the tumor and significantly reduces the diffusion of therapeutic agents (Jain, 2005).”
InfluentialMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467 · cited 5×
“…study suggests R-Ras as a potential target for controlling blood circulation and vascular permeability in solid tumors. processes of vessel formation and maturation are regulated by the balance between pro-angiogenic and antiangiogenic signals (Carmeliet and Jain, 2011a; Darland and D'Amore, 1999).”
InfluentialModes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 2×
“This study revealed a key role for R-Ras in promoting tum role, R-Ras expressed in endothelial cells and in pericytes bot suggests R-Ras as a potential target for controlling blood circ cally impacts tumor progression and tumors responses to therapeutic regimens (Bergers and Hanahan, 2008; Carmeliet and Jain, 2011b).”
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226 · cited 1×
“These findings are consistent with the fact that pericyte association with endothelium is crucial for vessel integrity (Lindahl et al., 1997; McDonald and Choyke, 2003).”
Endothelial/Pericyte Interactions
Armulik, A., Abramsson, A., & Betsholtz, C. (2005) · Circulation Research · doi:10.1161/01.res.0000182903.16652.d7 · Cited by 2,048 · cited 1×
“Pericytes interact closely with endothelial cells by adhering to the endothelial basement membrane that is shared by both cell types (Armulik et al., 2005).”
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299 · cited 1×
“This result corroborates the previous finding in gene expression profiling study, which revealed significantly reduced R-Ras mRNA level in the endothelium of human breast carcinoma compared with the normal counterpart (Allinen et al., 2004).”
Kappel, A., Rönicke, V., Damert, A., Flamme, I., Risau, W., & Breier, G. (1999) · Blood · doi:10.1182/blood.v93.12.4284 · Cited by 223
Bao, X., Moseman, E. A., Saito, H., Petryanik, B., Thiriot, A., Hatakeyama, S., Ito, Y., Kawashima, H., Yamaguchi, Y., Lowe, J. B., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.018 · Cited by 167
Self-citation
Cited by
Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges
Martin, J. D., Seano, G., & Jain, R. K. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114700 · Cited by 530
“Importantly, endothelial R-Ras does not induce EC death, as happens with classical antiangiogenic compounds, but it stimulates EC survival and vessel maturation (97).”
BackgroundCombining two strategies to improve perfusion and drug delivery in solid tumors
Stylianopoulos, T., & Jain, R. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318415110 · Cited by 508
Tumor and its microenvironment: A synergistic interplay
Catalano, V., Turdo, A., Di Franco, S., Dieli, F., Todaro, M., & Stassi, G. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.007 · Cited by 444
Hiraoka, N., Ino, Y., Yamazaki-Itoh, R., Kanai, Y., Kosuge, T., & Shimada, K. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.145 · Cited by 367
Yang, J., Li, W.-R., Lv, F.-H., He, S.-G., Tian, S.-L., Peng, W.-F., Sun, Y.-W., Zhao, Y.-X., Tu, X.-L., Zhang, M., et al. (2016) · Molecular Biology and Evolution · doi:10.1093/molbev/msw129 · Cited by 342
Vascular normalisation as the stepping stone into tumour microenvironment transformation
Magnussen, A. L., & Mills, I. G. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01330-z · Cited by 146
Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruption
Kim, C., Yang, H., Fukushima, Y., Saw, P. E., Lee, J., Park, J.-S., Park, I., Jung, J., Kataoka, H., Lee, D., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.010 · Cited by 131
Cappelli, H. C., Kanugula, A. K., Adapala, R. K., Amin, V., Sharma, P., Midha, P., Paruchuri, S., & Thodeti, C. K. (2019) · Cancer Letters · doi:10.1016/j.canlet.2018.07.042 · Cited by 54
Metadata
- Authors
- Sawada, J., Urakami, T., Li, F., Urakami, A., Zhu, W., Fukuda, M., Li, D. Y., Ruoslahti, E., & Komatsu, M.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 22
- Issue
- 2
- Pages
- 235-249
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2154084248
- Cited by
- 109
- References
- 8
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.